Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

Cotiviti, which is backed by KKR and Veritas Capital, has agreed to acquire Edifecs, a Bellevue, Washington-based healthcare data firm. No financial terms were disclosed. Francisco Partners and TA ...

Cotiviti, a leader in data-driven healthcare solutions, announces an agreement to acquire Edifecs, a pioneer in healthcare ...

The floodgates may not have fully opened for private equity deals in 2024, but KKR’s capital markets team led landmark financings for portfolio firms CyrusOne and Cotiviti and a string of ECM and ...

Goldman Sachs among lenders set to sell debt for buyout Total debt to rise to around $7 billion if merger goes ahead The total debt backing Cotiviti’s private equity owners buy-and-build strategy ...

$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025. Then $75 per month. Complete digital access to ...

Citi analyst Christopher Allen reiterated a Buy rating on KKR & Co (KKR – Research Report) today. The company’s shares closed yesterday at ...